Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2006 Dec;3(12):e540.
doi: 10.1371/journal.pmed.0030540.

HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects

Akinyemi I Ojesina, Phyllis J Kanki
Comment

HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects

Akinyemi I Ojesina et al. PLoS Med. 2006 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Comment on

References

    1. Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, et al. Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration. PLoS Med. 2005;2:e112. doi: 10.1371/journal.pmed.0020112. - DOI - PMC - PubMed
    1. Ojesina AI, Sankale J, Odaibo G, Langevin S, Meloni ST, et al. Subtype-specific patterns in HIV type 1 reverse transcriptase and protease in Oyo State, Nigeria: Implications for drug resistance and host response. AIDS Res Hum Retroviruses. 2006;22:770–779. - PubMed
    1. Stanford University. HIV drug resistance database: Detailed RT mutation query. 2006. Available: http://hivdb.stanford.edu/cgi-bin/RTMut.cgi. Accessed 21 November 2006.
    1. Thomson MM, Delgado E, Manjon N, Ocampo A, Villahermosa ML, et al. HIV-1 genetic diversity in Galicia, Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS. 2001;15:509–516. - PubMed
    1. Wainberg MA. HIV-1 subtype distribution and the problem of drug resistance. AIDS. 2004;18(Suppl 3):S63–S68. - PubMed

Substances